Perry L L, Williams I R, Dirusso S
J Immunol. 1984 Jul;133(1):16-23.
The induction of suppression by i.v. administered alloantigens in the murine host was analyzed as a model of the possible effects of blood transfusion on transplant survival. The results indicated that suppressor T cells (Ts) specific for minor histocompatibility alloantigens could be readily induced by the i.v. presentation of minor alloantigen-disparate spleen cells. In contrast, similar priming with cells differing solely at the H-2 major histocompatibility complex stimulated only positive T cell immunity, with no evidence of suppression. The induction of H-2 directed Ts activity could be accomplished only by i.v. priming with major plus minor incompatible donor cells, suggesting that suppressor cell recognition of minor alloantigens may have facilitated the generation of Ts against H-2-encoded major transplantation antigens. A role for minor histocompatibility antigens in the regulation of H-2-specific immunity at the effector level was also indicated. Ts induced by i.v. pretreatment with minor antigen-disparate donor cells not only suppressed the delayed-type hypersensitivity (DTH) response to the relevant minor alloantigens, but also inhibited DTH against unrelated H-2 alloantigens introduced during subsequent intradermal immunization. Suppression of H-2-directed T cell reactivity was specific in that the presence of the Ts-inducing minor alloantigens was also required and occurred only when the minor and unrelated major alloantigens were presented within the same inoculum, if not on the same cell surface. The capacity of Lyt-2+Ts or Ts-derived suppressive factors specific for one set of cell surface molecules to modulate responses to an unrelated group of surface antigens does not appear to represent a general phenomenon, because similar suppression of immunity to unrelated tumor-specific transplantation antigens by minor-specific Ts was not observed. These results are discussed with respect to the possible mechanism of H-2-directed suppression and the role of the I region in Ts recognition of antigen.
静脉注射同种异体抗原在鼠宿主中诱导免疫抑制作用,作为输血对移植存活可能影响的模型进行了分析。结果表明,静脉注射次要组织相容性异体抗原不同的脾细胞,可轻易诱导出针对次要组织相容性异体抗原的抑制性T细胞(Ts)。相比之下,仅在H-2主要组织相容性复合体上存在差异的细胞进行类似的致敏,仅刺激了阳性T细胞免疫,没有抑制的证据。只有通过静脉注射主要和次要不相容的供体细胞才能诱导出针对H-2的Ts活性,这表明抑制性细胞对次要异体抗原的识别可能促进了针对H-2编码的主要移植抗原的Ts的产生。次要组织相容性抗原在效应水平上对H-2特异性免疫调节中的作用也得到了证实。通过静脉注射用次要抗原不同的供体细胞进行预处理诱导的Ts,不仅抑制了对相关次要异体抗原的迟发型超敏反应(DTH),还抑制了后续皮内免疫期间引入的针对无关H-2异体抗原的DTH。对H-2定向T细胞反应性的抑制具有特异性,因为也需要存在诱导Ts的次要异体抗原,并且仅当次要和无关的主要异体抗原在同一接种物中呈现时才会发生,如果不是在同一细胞表面上呈现的话。针对一组细胞表面分子的Lyt-2+Ts或Ts衍生的抑制因子调节对无关表面抗原组反应的能力似乎并不代表一种普遍现象,因为未观察到次要特异性Ts对无关肿瘤特异性移植抗原免疫的类似抑制作用。针对H-2定向抑制的可能机制以及I区在Ts对抗原识别中的作用,对这些结果进行了讨论。